Michael Levy, M.D., Ph.D.

Physician Investigator (Cl)
Neurology, Mass General Research Institute
Associate Neurologist
Neurology, Massachusetts General Hospital
Associate Professor of Neurology
Harvard Medical School
M.D.; Ph.D. Baylor College of Medicine 2004
mog antibody disease; neuromyelitis optica; superficial siderosis; transverse myelitis

Dr. Michael Levy, MD, PhD, is an Associate Professor of Neurology at Massachusetts General Hospital and Research Director of the Division of Neuroimmunology & Neuroinfectious Disease. He completed the MD/PhD program at Baylor College of Medicine (Houston, TX) with a focus on neuroscience. Dr. Levy completed his Johns Hopkins internship in the Osler Medicine program, residency in the Johns Hopkins Neurology program and a fellowship in Neuroimmunology at Johns Hopkins University. In 2009, Dr. Levy was appointed to the faculty as Assistant Professor at Johns Hopkins where he started the Neuromyelitis Optica Clinic and Research Laboratory. 

Clinically, Dr. Levy specializes in taking care of patients with rare neuroimmunological diseases including neuromyelitis optica, transverse myelitis, MOG antibody disease, acute disseminated encephalomyelitis and optic neuritis. In addition to neuroimmunology clinics, Dr. Levy has a special interest in patients with superficial siderosis of the central nervous system. Dr. Levy is the principal investigator on several clinical studies and drug trials for all of these conditions. 

In the laboratory, Dr. Levy’s research focuses on the development of animal models of neuromyelitis optica and transverse myelitis with the goal of tolerization as a sustainable long term treatment. His lab is focused on understand the immunopathogenic mechanisms of these rare autoimmune diseases. They have expertise in animal models of these diseases which we also use to study pathogenic mechanisms of autoimmunity. The goal is to translate these findings to human trials driven by the unmet need in the neuroimmunology clinic.